GAITHERSBURG, Md., Dec. 1 /PRNewswire-FirstCall/ -- MedImmune, Inc.
(Nasdaq: MEDI) announced today that the Washington Business Journal has named
Linda J. Peters, MedImmune's senior vice president, regulatory affairs, as one
of the region's leading business women. Ms. Peters was recognized at the 2006
"Women Who Mean Business" awards reception held Thursday, November 30 in
The "Women Who Mean Business" award honors 25 influential women for
significant contributions to their local communities and to the Greater
Washington business area. In its third year, the program recognizes women
across all industries and professions.
"Linda's professional accomplishments, dedication to her work and
commitment to corporate community involvement establish her as an exemplary
leader for other women in her field," said David M. Mott, MedImmune president
and chief executive officer. "She has built a strong, diverse regulatory
affairs team at MedImmune, fostering mentorship and expanding the regulatory
group's role as a collaborative partner for other functions within the
Since Ms. Peters joined MedImmune in February 2005, the biotechnology
company's regulatory affairs organization has nearly doubled in size, and the
number of regulatory-related filings to the U.S. Food and Drug Administration
(FDA) and other regulatory agencies has already exceeded 1,000 this year. Her
successful development and expansion of the regulatory function has helped to
advance MedImmune's strategic priorities and to establish scalable processes
in a time of rapid growth for the company. Recent company milestones
resulting in part from Peters' leadership include filing supplemental
biologics license applications (sBLAs) for approval of the MedImmune's next-
generation intranasal influenza vaccine, filing several Investigational New
Drug (IND) applications, and breaking ground on a new cell culture
manufacturing facility in Frederick, MD.
"Achievement of these critical milestones requires a tremendous amount of
regulatory support, and Linda and her team have not only met those needs with
great success, but have gone even further to develop and implement processes
to help MedImmune continue its extraordinary pattern of growth and success,"
said Lota S. Zoth, MedImmune's senior vice president and chief financial
officer, and a recipient of this leadership award in 2004.
In addition to her professional accomplishments, Ms. Peters' recognition
as a "Woman Who Means Business" reflects her mentorship of other women in her
field and her involvement in volunteer and community-focused activities. She
advocates strong corporate community involvement and leads by example; she
also actively supports several organizations dedicated to cancer-related
research and assisting families of children with cancer.
Ms. Peters earned a bachelor's and a master's degree in animal science
from Southern Illinois University. She obtained a master's degree in business
administration from the J.L. Kellogg School of Management at Northwestern
University. Prior to joining MedImmune, Ms. Peters was vice president of
global regulatory affairs for the Bioscience and Renal Divisions of Baxter
Healthcare. She also held positions of increasing responsibility and Takeda
Pharmaceuticals and TAP Pharmaceuticals.
Additional Local Recognition for MedImmune, Inc.
Separately, MedImmune was recently awarded the 2006 Economic Development
and Advancement Award from the Montgomery County Department of Economic
Development, which is presented to individuals or employers in Montgomery
County who consistently make economic development and workforce development a
priority. The company's legal department was also recently named a finalist
in the "Outstanding Law Department of the Year" category at the 2006
Washington Metropolitan Area Corporate Counsel Association (WMACCA) Corporate
Counsel Awards. In addition, the Maryland Partnership for Prevention recently
presented the "2006 Immunization Partnership Award" to Mary Ellen Enos,
MedImmune legislation analyst, for outstanding efforts to help prevent and
reduce vaccine-preventable diseases in Maryland. MedImmune, in partnership
with the Maryland Governor's office and the Centers for Disease Control &
Prevention, provided free doses of influenza vaccine for Maryland's elementary
school-aged children this year. The award was presented at the 2006 Maryland
Immunization Excellence Awards Luncheon in Columbia, Maryland.
About MedImmune, Inc.
MedImmune strives to provide better medicines to patients, new medical
options for physicians, rewarding careers to employees, and increased value to
shareholders. Dedicated to advancing science and medicine to help people live
better lives, the company is focused on the areas of infectious diseases,
cancer and inflammatory diseases. With more than 2,500 employees worldwide,
MedImmune is headquartered in Maryland. For more information, visit the
company's website at http://www.medimmune.com.
This announcement may contain, in addition to historical information,
certain forward-looking statements that involve risks and uncertainties. Such
statements reflect management's current views and are based on certain
assumptions. Actual results could differ materially from those currently
anticipated as a result of a number of factors, including risks and
uncertainties discussed in the company's filings with the U.S. Securities and
Exchange Commission. The company is developing several products for potential
future marketing. There can be no assurance that such development efforts
will succeed, that such products will receive required regulatory clearance or
that, even if such regulatory clearance were received, such products would
ultimately achieve commercial success.
SOURCE MedImmune, Inc.
CONTACT: Media: Kate Barrett, +1-301-398-4320, or Investors: Beatrice
Pierre, +1-301-398-4905, both of MedImmune, Inc.